F20.16 can be used as an in vitro marker of terminally differentiated breast lumenal epithelial cells.
| Inventor | Institute |
|---|---|
| Joy Burchell ; Joyce Taylor-Papadimitriou | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| SKU: | 151095 |
|---|---|
| Product description: | F20.16 can be used as an in vitro marker of terminally differentiated breast lumenal epithelial cells. |
| Conjugation: | Unconjugated |
| Isotype: | IgM |
| Molecular weight: | 14 kDa |
| Immunogen: | Purified casein and a-lactalbumin. |
| Myeloma used: | P3X63Ag8.653 |
| Cat. #: | 151095 |
|---|---|
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cancer;Cell biology;Immunology |
| Application: | IHC ; IF ; WB |
| Target: | Lactalbumin (alpha) |
| Reactivity: | Human |
| Clone: | F20.16 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | Alpha-lactalbumin is a small calcium-binding component of lactose synthase. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Burchell et al. 1985. Hybridoma. 4(4):341-50. PMID: 3905581. Production and characterization of monoclonal antibodies to human casein. A monoclonal antibody that cross-reacts with casein and alpha-lactalbumin. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.